Related references
Note: Only part of the references are listed.A systematic assessment of statistics, risk factors, and underlying features involved in pancreatic cancer
Imlimaong Aier et al.
CANCER EPIDEMIOLOGY (2019)
Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2
Teresa Macarulla et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Efficacy and safety of gemcitabine plus anti-angiogenesis therapy for advanced pancreatic cancer: a systematic review and meta-analysis of clinical randomized phase III trials
Mengting Tong et al.
JOURNAL OF CANCER (2019)
Molecular Targets of EpigallocatechinGallate (EGCG): A Special Focus on Signal Transduction and Cancer
Aide Negri et al.
NUTRIENTS (2018)
Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models
Ran Wei et al.
FOOD & FUNCTION (2018)
Role of Epithelial-Mesenchymal Transition in Tumor Progression
N. A. Gloushankova et al.
BIOCHEMISTRY-MOSCOW (2018)
Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review
Ren-You Gan et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2018)
A central role for cadherin signaling in cancer
Antonis Kourtidis et al.
EXPERIMENTAL CELL RESEARCH (2017)
Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity
Vikrant Borse et al.
CELL DEATH & DISEASE (2017)
(-)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt/β-Catenin Pathway
Yue Chen et al.
NUTRIENTS (2017)
Down-regulation of C35 decreased the cell viability and migration of breast ductal carcinoma cells
Wen Che et al.
PLOS ONE (2017)
The novel agent phospho-glycerol-ibuprofen-amide (MDC-330) inhibits glioblastoma growth in mice: an effect mediated by cyclin D1
Lauren E. Bartels et al.
CARCINOGENESIS (2016)
Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
Andreia Granja et al.
NUTRIENTS (2016)
EGCG Inhibits Proliferation, Invasiveness and Tumor Growth by Up-Regulation of Adhesion Molecules, Suppression of Gelatinases Activity, and Induction of Apoptosis in Nasopharyngeal Carcinoma Cells
Chih-Yeu Fang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition
Wenting Xu et al.
CELL ADHESION & MIGRATION (2015)
Targeting mTOR dependency in pancreatic cancer
Douglas C. Morran et al.
GUT (2014)
Biochemical and Cellular Evidence Demonstrating AKT-1 as a Binding Partner for Resveratrol Targeting Protein NQO2
Tze-Chen Hsieh et al.
PLOS ONE (2014)
Targeting Mitochondrial STAT3 with the Novel Phospho-Valproic Acid (MDC-1112) Inhibits Pancreatic Cancer Growth in Mice
Gerardo G. Mackenzie et al.
PLOS ONE (2013)
EGCG Enhances the Therapeutic Potential of Gemcitabine and CP690550 by Inhibiting STAT3 Signaling Pathway in Human Pancreatic Cancer
Su-Ni Tang et al.
PLOS ONE (2012)
Phospho-Sulindac (OXT-328) Combined with Difluoromethylornithine Prevents Colon Cancer in Mice
Gerardo G. Mackenzie et al.
CANCER PREVENTION RESEARCH (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
Biomarkers for epithelial-mesenchymal transitions
Michael Zeisberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-κB and STAT3 pathways in Hodgkin's lymphoma cells
Gerardo G. Mackenzie et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity
K. Aigner et al.
ONCOGENE (2007)
Microtubules are required for NF-κB nuclear translocation in neuroblastoma IMR-32 cells:: modulation by zinc
Gerardo G. Mackenzie et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation
Paolo Piacentini et al.
VIRCHOWS ARCHIV (2006)
Epithelial-mesenchymal transition in development and cancer:: role of phosphatidylinositol 3′ kinase/AKT pathways
L Larue et al.
ONCOGENE (2005)
Insulin receptor substrate is a mediator of phosphoinositide 3-kinase activation in quiescent pancreatic cancer cells
T Asano et al.
CANCER RESEARCH (2005)
The rapamycin analog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation
T Asano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Invasion and metastasis in colorectal cancer: Epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin
T Brabletz et al.
CELLS TISSUES ORGANS (2005)
Akt/PKB signaling mechanisms in cancer and chemoresistance
D Kim et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
Artifacts in cell culture: Rapid generation of hydrogen peroxide on addition of (-)-epigallocatechin, (-)-epigallocatechin gallate, (+)-catechin, and quercetin to commonly used cell culture media
LH Long et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)